Journal: PLOS Pathogens
Article Title: Targeting n-myristoyltransferases promotes a pan- Mammarenavirus inhibition through the degradation of the Z matrix protein
doi: 10.1371/journal.ppat.1012715
Figure Lengend Snippet: (A-C) A549 cells were infected with YFV 17D, MOPV (A), LASV (B), or MACV (C) at MOI 0.01 for 1 h. Before, during and after infection, cells were treated or not with 10 fold dilutions of IMP1088, DDD85646 or C75 ranging from 1 nM to 10 μM. After 48 h of infection, cell culture supernatants were titrated (left panels) while cell viability was measured (right panels). The results of three independent experiments are represented as mean +/- SEM and expressed as FFU/mL for titrations and standardized to mock condition for viability. (D) Measure of the potential virucidal effect of IMP1088, DDD85646 and C75 on MOPV particles. 10 5 FFU of MOPV were incubated for 1 h with 10 μM of each compounds and were then titrated. The results of three independent experiments are represented as mean +/- SEM and expressed as FFU/mL. (E) Potency of IMP1088 and DDD85646 against MOPV, LASV, LCMV, LUJV, MACV or JUNV. A549 cells were infected (MOI 0.01) and treated or not with IMP1088 (20 nM), DDD85646 or C75 (500 nM) as described above. Cell culture supernatant were titrated and results of three independent experiments expressed as mean percentage +/- SEM to mock treated condition. P <0.05 (*) and <0.001 (***).
Article Snippet: The IMP1088, 5-[3,4-difluoro-2-[2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethoxyphenyl]-N,N,1-trimethyl-1H-indazole-3-methanamine (CAS 2059148-82-0), DDD85646, 2,6-dichloro-4-[2-(1-piperazinyl)-4-pyridinyl]-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)-benzenesulfonamide (CAS 1215010-55-1) and C75, tetrahydro-4-methylene-2R-octyl-5-oxo-3S-furancarboxylic acid (CAS 191282-48-1) were purchased from Cayman Chemicals.
Techniques: Infection, Cell Culture, Incubation